Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Dermatology

Free Subscription 19.12.2022 6 Am J Dermatopathol 1 Am J Ophthalmol 1 Am J Pathol 14 BMC Cancer 3 Cancer 3 Cancer Res 20 Clin Dermatol 6 Hum Mutat 1 Int J Cancer 1 Int J Clin Pract 4 Int J Dermatol 1 J Cutan Pathol 6 J Dermatol 8 J Invest Dermatol 2 Lancet 4 N Engl J Med 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. SALEHI S, Sadeghi S, Kalantari Y, Goodarzi A, et al
   A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations.
   Am J Dermatopathol. 2023;45:1-27.
   PubMed         Abstract available
   
   
2. HUI ONG EL, Cooray S, Brogan P, Calonje E, et al
   Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2.
   Am J Dermatopathol. 2023;45:47-50.
   PubMed         Abstract available
   
   
3. HARTSOUGH EM, Moran J, Devins K, Wszolek M, et al
   An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
   Am J Dermatopathol. 2023;45:51-55.
   PubMed         Abstract available
   
   
4. ZIPPERER K, Munoz A, Kelly E, Goodwin B, et al
   Acquired Perforating Osteoma Cutis: A Rare Histopathological Diagnosis.
   Am J Dermatopathol. 2023;45:56-57.
   PubMed         Abstract available
   
   
5. PIXLEY JN, Kozak M, Rusu C, Raghavan S, et al
   Diffuse Vesicular Rash: Answer.
   Am J Dermatopathol. 2023;45:69-70.
   PubMed        
   
   
6. PIXLEY JN, Kozak M, Rusu C, Raghavan S, et al
   Diffuse Vesicular Rash: Challenge.
   Am J Dermatopathol. 2023;45:e1-e2.
   PubMed        
   
   

   
   Am J Ophthalmol

7. LEE H, Purohit R, Sheth V, Maconachie G, et al
   Retinal development in infants and young children with albinism: evidence for plasticity in early childhood.
   Am J Ophthalmol. 2022 Sep 6. pii: S0002-9394(22)00344.
   PubMed         Abstract available
   
   

   
   Am J Pathol

8. FURTH PA, Wang W, Kang K, Rooney BL, et al
   Overexpression of Estrogen Receptor alpha in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor alpha-Positive Mammary Adenocarcinomas.
   Am J Pathol. 2023;193:103-120.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. BRUAND M, Salleron J, Guihard S, Crety CM, et al
   Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.
   BMC Cancer. 2022;22:1318.
   PubMed         Abstract available
   
   
10. GENG SK, Fu SM, Zhang HW, Fu YP, et al
    Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer.
    BMC Cancer. 2022;22:1328.
    PubMed         Abstract available
    
    
11. ZHANG GY, Zhang R, Bai P, Li SM, et al
    Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    BMC Cancer. 2022;22:1331.
    PubMed         Abstract available
    
    
12. KLAESTAD E, Opdahl S, Raj SX, Bofin AM, et al
    Long term trends of breast cancer incidence according to proliferation status.
    BMC Cancer. 2022;22:1340.
    PubMed         Abstract available
    
    
13. YAO H, Li N, Yuan H
    Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations.
    BMC Cancer. 2022;22:1337.
    PubMed         Abstract available
    
    
14. YOUSEFI H, Bahramy A, Zafari N, Delavar MR, et al
    Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer.
    BMC Cancer. 2022;22:1282.
    PubMed         Abstract available
    
    
15. LI M, Zheng Y, Li X, Shen X, et al
    ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer.
    BMC Cancer. 2022;22:1280.
    PubMed         Abstract available
    
    
16. ZHU P, Liu G, Wang X, Lu J, et al
    Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis.
    BMC Cancer. 2022;22:1283.
    PubMed         Abstract available
    
    
17. OSMANI V, Fett S, Tauscher M, Donnachie E, et al
    HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    BMC Cancer. 2022;22:1293.
    PubMed         Abstract available
    
    
18. VOUTILAINEN S, Heikkila P, Bartkova J, Nevanlinna H, et al
    Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of gammaH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 cases.
    BMC Cancer. 2022;22:1298.
    PubMed         Abstract available
    
    
19. BODARD S, Lassalle L, Larousserie F, Guinebert S, et al
    Performance of Sonoelastography for predicting malignancy in soft tissue.
    BMC Cancer. 2022;22:1305.
    PubMed         Abstract available
    
    
20. SIRAIT LMF, Hamajima N, Suzuki Y, Wahyuningsih ES, et al
    Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: a cross-sectional study.
    BMC Cancer. 2022;22:1309.
    PubMed         Abstract available
    
    
21. TERASHIMA T, Konishi H, Sato Y, Igarashi M, et al
    Impact of coronavirus disease 2019 on the number of newly diagnosed cancer patients and examinations and surgeries performed for cancer in Japan: a nationwide study.
    BMC Cancer. 2022;22:1303.
    PubMed         Abstract available
    
    
22. SCHOFFSKI P, George S, Heinrich MC, Zalcberg JR, et al
    Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial.
    BMC Cancer. 2022;22:1302.
    PubMed         Abstract available
    
    

    
    Cancer

23. HOXHAJ A, Drissen MMCM, Vos JR, Bult P, et al
    The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
    Cancer. 2022;128:2883-2891.
    PubMed         Abstract available
    
    
24. ELLINGTON TD, Henley SJ, Wilson RJ, Miller JW, et al
    Trends in breast cancer mortality by race/ethnicity, age, and US census region, United States horizontal line 1999-2020.
    Cancer. 2022 Oct 30. doi: 10.1002/cncr.34503.
    PubMed         Abstract available
    
    
25. 
    Updated ASCO guidelines for patients with HER2-positive breast cancer.
    Cancer. 2023;129:10.
    PubMed        
    
    

    
    Cancer Res

26. DURO-SANCHEZ S, Nadal-Serrano M, Lalinde-Gutierrez M, Arenas EJ, et al
    Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer.
    Cancer Res. 2022 Oct 12. pii: 709715. doi: 10.1158/0008-5472.CAN-22-0787.
    PubMed         Abstract available
    
    
27. HONG J, Lee JH, Zhang Z, Wu Y, et al
    PRC2-mediated epigenetic suppression of type I IFN-STAT2 signaling impairs antitumor immunity in luminal breast cancer.
    Cancer Res. 2022 Oct 12. pii: 709714. doi: 10.1158/0008-5472.CAN-22-0736.
    PubMed         Abstract available
    
    
28. ELKHOLI IE, Lalonde A, Park M, Cote JF, et al
    Breast Cancer Metastatic Dormancy and Relapse: An enigma of microenvironment(s).
    Cancer Res. 2022 Oct 10. pii: 709673. doi: 10.1158/0008-5472.CAN-22-1902.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

29. ATZORI L, Ferreli C, Mateeva V, Vassileva S, et al
    Clinicopathologic features among different viral epidemic outbreaks involving the skin.
    Clin Dermatol. 2022;40:573-585.
    PubMed         Abstract available
    
    
30. LIU WT, Sun PL, Bramono K, Ezmerli M, et al
    Annular infectious dermatoses.
    Clin Dermatol. 2022;40:427-440.
    PubMed         Abstract available
    
    
31. ORNEK S, Zuberbier T, Kocaturk E
    Annular urticarial lesions.
    Clin Dermatol. 2022;40:480-504.
    PubMed         Abstract available
    
    
32. SUSSMAN M, Zhai L, Morquette A, Huang S, et al
    Annular bullous diseases.
    Clin Dermatol. 2022;40:516-528.
    PubMed         Abstract available
    
    
33. ASLAN KAYIRAN M, Wang JV, Karadag AS
    Papulosquamous annular diseases.
    Clin Dermatol. 2022;40:441-449.
    PubMed         Abstract available
    
    
34. HOFFMAN M, Renzi M Jr, Heymann WR
    Pathogenesis of annular lesions: Why a ring presentation?
    Clin Dermatol. 2022;40:420-426.
    PubMed         Abstract available
    
    
35. WU WH, Chu CY
    Annular drug eruptions.
    Clin Dermatol. 2022;40:450-465.
    PubMed         Abstract available
    
    
36. DRAGO F, Broccolo F, Ciccarese G
    Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
    Clin Dermatol. 2022;40:586-590.
    PubMed         Abstract available
    
    
37. SHAH N, Ghatnekar S, Nambudiri VE
    Variability of over-the-counter spending on acne treatment across race and demographic characteristics.
    Clin Dermatol. 2022;40:564-566.
    PubMed         Abstract available
    
    
38. SCHROEDER JW, Gamba C, Toniato A, Rongioletti F, et al
    A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2.
    Clin Dermatol. 2022;40:591-594.
    PubMed         Abstract available
    
    
39. CAPUTO V, Bonoldi E, Citterio A, Rongioletti F, et al
    The challenge of Morgellons disease: A patient with clinicopathologic correlation.
    Clin Dermatol. 2022;40:686-690.
    PubMed         Abstract available
    
    
40. LITAIEM N, Baklouti M, Zeglaoui F
    Side effects of gel nail polish: A systematic review.
    Clin Dermatol. 2022;40:706-715.
    PubMed         Abstract available
    
    
41. SHAH RR, Lambert WC, Schwartz RA
    Birt-Hogg-Dube syndrome: Another mTOR phenomenon.
    Clin Dermatol. 2022;40:700-705.
    PubMed         Abstract available
    
    
42. MAGRO CM, Mo JH, Kerns MJ
    Leukocytoclastic vasculitis in association with linear epidermal basement membrane zone immunoglobulin deposition: Linear vasculitis.
    Clin Dermatol. 2022;40:639-650.
    PubMed         Abstract available
    
    
43. MAGRO CM, Mo JH, Telang G
    Localized lymphomatoid papulosis: Unilesional lymphomatoid papulosis, regional lymphomatoid papulosis, and persistent agmination of lymphomatoid papulosis.
    Clin Dermatol. 2022;40:622-638.
    PubMed         Abstract available
    
    
44. FARAHBAKHSH N, Della Porta A, Monir RL, Guo W, et al
    Training dermatology residents in dermatoscopy: A case control lecture series assessment.
    Clin Dermatol. 2022;40:782-787.
    PubMed         Abstract available
    
    
45. RUSSELL AP, Gailey JH, Abdulkarim B, Levell NJ, et al
    Dermatographism in popular culture.
    Clin Dermatol. 2022;40:768-772.
    PubMed         Abstract available
    
    
46. COHEN PR
    ABA supports AMA regarding monkeypox name change: A satire.
    Clin Dermatol. 2022;40:808-809.
    PubMed         Abstract available
    
    
47. CAPOSIENA CARO RD, Molinelli E, Rosi E, Chiricozzi A, et al
    Anogenital involvement: Clinical sign of severity in hidradenitis suppurativa.
    Clin Dermatol. 2022;40:541-543.
    PubMed        
    
    
48. KYRIAKOU G, Kyriakou A, Papanikolaou S, Glentis A, et al
    Don't worry about a thing ... every little thing gonna be all right (except for acral lentiginous melanoma).
    Clin Dermatol. 2022;40:613-616.
    PubMed         Abstract available
    
    

    
    Hum Mutat

49. VAHIDNEZHAD H, Youssefian L, Harvey N, Tavasoli AR, et al
    Mutation update: The spectra of PLEC sequence variants and related plectinopathies.
    Hum Mutat. 2022;43:1706-1731.
    PubMed         Abstract available
    
    
50. MINATOGAWA M, Hirose T, Mizumoto S, Yamaguchi T, et al
    Clinical and pathophysiological delineation of musculocontractural Ehlers-Danlos syndrome caused by dermatan sulfate epimerase deficiency (mcEDS-DSE): A detailed and comprehensive glycobiological and pathological investigation in a novel patient.
    Hum Mutat. 2022;43:1829-1836.
    PubMed         Abstract available
    
    
51. COLMAN M, Vroman R, Dhooge T, Malfait Z, et al
    Kyphoscoliotic Ehlers-Danlos syndrome caused by pathogenic variants in FKBP14: Further insights into the phenotypic spectrum and pathogenic mechanisms.
    Hum Mutat. 2022;43:1994-2009.
    PubMed         Abstract available
    
    
52. SAVAGE SA, Jones K, Teshome K, Lori A, et al
    Next-generation sequencing errors due to genetic variation in WRAP53 encoding TCAB1 on chromosome 17.
    Hum Mutat. 2022;43:1856-1859.
    PubMed         Abstract available
    
    
53. LANZAFAME M, Nardo T, Ricotti R, Pantaleoni C, et al
    TFIIH stabilization recovers the DNA repair and transcription dysfunctions in thermo-sensitive trichothiodystrophy.
    Hum Mutat. 2022;43:2222-2233.
    PubMed         Abstract available
    
    
54. SZERI F, Miko A, Navasiolava N, Kaposi A, et al
    The pathogenic c.1171A>G (p.Arg391Gly) and c.2359G>A (p.Val787Ile) ABCC6 variants display incomplete penetrance causing pseudoxanthoma elasticum in a subset of individuals.
    Hum Mutat. 2022;43:1872-1881.
    PubMed         Abstract available
    
    

    
    Int J Cancer

55. KANKURI-TAMMILEHTO M, Tervasmaki A, Kraatari-Tiri M, Rahikkala E, et al
    ATM c.7570G>C is a high-risk allele for breast cancer.
    Int J Cancer. 2022 Sep 26. doi: 10.1002/ijc.34305.
    PubMed         Abstract available
    
    

    
    Int J Clin Pract

56. ISLAM MA, Sathi NJ, Abdullah HM, Tabassum T, et al
    A Meta-Analysis of Induced Abortion, Alcohol Consumption, and Smoking Triggering Breast Cancer Risk among Women from Developed and Least Developed Countries.
    Int J Clin Pract. 2022;2022:6700688.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

57. FERNANDEZ JM, Kwan KR, Mata EM, Bubic BN, et al
    Primary cutaneous melanoma in Asian Americans: a retrospective cohort analysis of 1,179 cases from the National Cancer Database.
    Int J Dermatol. 2022 Dec 14. doi: 10.1111/ijd.16562.
    PubMed        
    
    
58. NARANG J, Gallop J, Cassard L, Seck S, et al
    Vascular cutaneous manifestations, especially in men, are associated with a more severe disease course in COVID-19 patients.
    Int J Dermatol. 2022 Dec 14. doi: 10.1111/ijd.16558.
    PubMed        
    
    
59. SHAREEF SJ, Ashack K
    Cutaneous larva migrans: the unexpected souvenir.
    Int J Dermatol. 2022 Dec 14. doi: 10.1111/ijd.16551.
    PubMed        
    
    
60. SONG X, Dai W, Wu YJ, Wu YX, et al
    A case of pancreatitis-panniculitis-polyarthritis syndrome due to pancreatic neuroendocrine tumor.
    Int J Dermatol. 2022 Dec 13. doi: 10.1111/ijd.16554.
    PubMed        
    
    

    
    J Cutan Pathol

61. CLEMENTS SA, Kelley BF, Rivera L, Greenway HT, et al
    Neurotropic Melanoma arising from a Neurocristic Hamartoma.
    J Cutan Pathol. 2022 Dec 14. doi: 10.1111/cup.14378.
    PubMed         Abstract available
    
    

    
    J Dermatol

62. YU L, Wei L, Ma L, Li L, et al
    First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol.
    J Dermatol. 2022 Dec 10. doi: 10.1111/1346-8138.16657.
    PubMed        
    
    
63. ISHIKAWA M, Yamamoto T
    Interstitial granulomatous dermatitis in a patient with systemic lupus erythematosus presenting with rope sign.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16674.
    PubMed        
    
    
64. TAKAHASHI A, Namikawa K, Ogata D, Jinnai S, et al
    Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16669.
    PubMed         Abstract available
    
    
65. KAWAKAMI T, Yokoyama K, Ikeda T, Tomizawa H, et al
    Presence of eosinophil extracellular trap cell death in the affected skin of eosinophilic granulomatosis with polyangiitis.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16656.
    PubMed         Abstract available
    
    
66. YAMANAKA K, Okubo Y, Yasuda I, Saito N, et al
    Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16667.
    PubMed         Abstract available
    
    
67. YOKOI K, Watanabe R, Kume M, Yamane S, et al
    Melanocyte-specific CD49a(+) CD8(+) T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.
    J Dermatol. 2022 Dec 14. doi: 10.1111/1346-8138.16680.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

68. SUN J, Zhou J, Zhou J, Xu W, et al
    FGF4 promotes skin wound repair through p38 MAPK and GSK3beta-mediated stabilization of Slug.
    J Invest Dermatol. 2022 Dec 12:S0022-202X(22)02845.
    PubMed         Abstract available
    
    
69. KARMON M, Kopel E, Barzilai A, Geva P, et al
    Altered RNA editing in Atopic Dermatitis highlights the role of dsRNA for immune surveillance.
    J Invest Dermatol. 2022 Dec 8:S0022-202X(22)02837.
    PubMed         Abstract available
    
    
70. CHEN XY, Xu F, Chen JQ, Landeck L, et al
    UBE2L3 Reduces TRIM21 Expression and Interleukin-1beta Secretion in Epidermal Keratinocytes and Improves Psoriasis-like Skin.
    J Invest Dermatol. 2022 Dec 8:S0022-202X(22)02819.
    PubMed         Abstract available
    
    
71. GONZALEZ JR, Celli A, Weckel A, Dhariwala MO, et al
    Filaggrin deficiency in mice alters the early life CD4(+) T cell response to skin commensal bacteria.
    J Invest Dermatol. 2022 Dec 7:S0022-202X(22)02822.
    PubMed         Abstract available
    
    
72. HU T, Todberg T, Ewald DA, Hoof I, et al
    Assessment of Spatial and Temporal Variation in the Skin Transcriptome of Atopic Dermatitis by Use of 1.5 mm Mini Punch Biopsies.
    J Invest Dermatol. 2022 Dec 7:S0022-202X(22)02657.
    PubMed         Abstract available
    
    
73. ZHANG L, Qiu L, Wu J, Qi Y, et al
    GWAS of Chronic Spontaneous Urticaria Reveals Genetic Overlap with Autoimmune Diseases, Not Atopic Diseases.
    J Invest Dermatol. 2023;143:67-77.
    PubMed         Abstract available
    
    
74. CHIMBETETE T, Buck C, Choshi P, Selim R, et al
    HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity.
    J Invest Dermatol. 2022 Dec 20:S0022-202X(22)02769.
    PubMed         Abstract available
    
    
75. GUPTA I, Shankrit S, Narta K, Ghazi M, et al
    Whole exome-sequencing of vitiligo lesions indicate lower burden of somatic variations: implications in risk for non-melanoma skin cancers.
    J Invest Dermatol. 2022 Dec 16:S0022-202X(22)02884.
    PubMed        
    
    

    
    Lancet

76. GUTTMAN-YASSKY E, Simpson EL, Reich K, Kabashima K, et al
    An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study.
    Lancet. 2022 Dec 9:S0140-6736(22)02037-2. doi: 10.1016/S0140-6736(22)02037.
    PubMed         Abstract available
    
    
77. THYSSEN JP, Schmid-Grendelmeier P
    Long-term disease control in atopic dermatitis using biologics.
    Lancet. 2022 Dec 9:S0140-6736(22)02347-9. doi: 10.1016/S0140-6736(22)02347.
    PubMed        
    
    

    
    N Engl J Med

78. PAYNE AS
    Topical Gene Therapy for Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2281-2284.
    PubMed        
    
    
79. SCHAFFER DV
    The Coming of Age of Topical Gene Therapy for Dystrophic Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2279-2280.
    PubMed        
    
    
80. GUIDE SV, Gonzalez ME, Bagci IS, Agostini B, et al
    Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
    N Engl J Med. 2022;387:2211-2219.
    PubMed         Abstract available
    
    
81. VIEDMA-MARTINEZ M, Villegas Romero I
    Skin Necrosis after Transarterial Chemoembolization.
    N Engl J Med. 2022;387:2268.
    PubMed        
    
    

    
    PLoS One

82. ZHANG S, Wang H, Liu B, Yu J, et al
    Socioeconomic status index is an independent determinant of breast cancer screening practices: Evidence from Eastern China.
    PLoS One. 2022;17:e0279107.
    PubMed         Abstract available
    
    
83. SCHRADER NHB, Duipmans JC, Renken RJ, Soros P, et al
    The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.
    PLoS One. 2022;17:e0277512.
    PubMed         Abstract available
    
    
84. WANG S, Wang J, Zhu MX, Tan Q, et al
    Machine learning for the prediction of minor amputation in University of Texas grade 3 diabetic foot ulcers.
    PLoS One. 2022;17:e0278445.
    PubMed         Abstract available
    
    
85. QI SA, Kumar N, Xu JY, Patel J, et al
    Personalized breast cancer onset prediction from lifestyle and health history information.
    PLoS One. 2022;17:e0279174.
    PubMed         Abstract available
    
    
86. GUNDOGMUS AG, Sezer Katar K, Orsel S, Ozturk G, et al
    The relationship of potential biomarkers with psychological resilience and post-traumatic growth in female patients with breast cancer.
    PLoS One. 2022;17:e0277119.
    PubMed         Abstract available
    
    
87. LING AY, Jreich R, Montez-Rath ME, Meng Z, et al
    Transporting observational study results to a target population of interest using inverse odds of participation weighting.
    PLoS One. 2022;17:e0278842.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: